CERS vs KEYS · rev $201.3M vs P/E 57, rev $4.98B
Cerus Corporation (CERS) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
Cerus Corporation (CERS) is a medical devices company listed on US.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported CERS revenue for 2024-12-31 was $201.3M. Net income was -$21.0M. Revenue was up 7.8% from 2023-12-31 to 2024-12-31. CERS currently screens at market cap $294.4M.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
CERS currently screens at market cap $294.4M. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the CERS and KEYS stock pages for the full models.
Not investment advice.